These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 37273120)

  • 21. Autosomal dominant hyper-IgE syndrome: When hematopoietic stem cell transplantation should be considered?
    Oikonomopoulou C; Goussetis E
    Pediatr Transplant; 2020 Aug; 24(5):e13699. PubMed ID: 32497403
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of the Role of
    Moffitt K; Cheung E; Manis J; Malley R
    Infect Immun; 2018 May; 86(5):. PubMed ID: 29463618
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutations in STAT3 and diagnostic guidelines for hyper-IgE syndrome.
    Woellner C; Gertz EM; Schäffer AA; Lagos M; Perro M; Glocker EO; Pietrogrande MC; Cossu F; Franco JL; Matamoros N; Pietrucha B; Heropolitańska-Pliszka E; Yeganeh M; Moin M; Español T; Ehl S; Gennery AR; Abinun M; Breborowicz A; Niehues T; Kilic SS; Junker A; Turvey SE; Plebani A; Sánchez B; Garty BZ; Pignata C; Cancrini C; Litzman J; Sanal O; Baumann U; Bacchetta R; Hsu AP; Davis JN; Hammarström L; Davies EG; Eren E; Arkwright PD; Moilanen JS; Viemann D; Khan S; Maródi L; Cant AJ; Freeman AF; Puck JM; Holland SM; Grimbacher B
    J Allergy Clin Immunol; 2010 Feb; 125(2):424-432.e8. PubMed ID: 20159255
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Single-cell multi-omics sequencing reveals the immunological disturbance underlying STAT3-V637M Hyper-IgE syndrome.
    Zhong J; Qiu M; Meng Y; Wang P; Chen S; Wang L
    Int Immunopharmacol; 2023 Sep; 122():110624. PubMed ID: 37480751
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Hyper-IgE syndromes].
    He YY; Liu B; Xiao XP
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jun; 31(11):892-896. PubMed ID: 29775011
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Variable clinical expressivity of STAT3 mutation in hyperimmunoglobulin E syndrome: genetic and clinical studies of six patients.
    Wolach O; Kuijpers T; Ben-Ari J; Gavrieli R; Feinstein-Goren N; Alders M; Garty BZ; Wolach B
    J Clin Immunol; 2014 Feb; 34(2):163-70. PubMed ID: 24452316
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atopic dermatitis, STAT3- and DOCK8-hyper-IgE syndromes differ in IgE-based sensitization pattern.
    Boos AC; Hagl B; Schlesinger A; Halm BE; Ballenberger N; Pinarci M; Heinz V; Kreilinger D; Spielberger BD; Schimke-Marques LF; Sawalle-Belohradsky J; Belohradsky BH; Przybilla B; Schaub B; Wollenberg A; Renner ED
    Allergy; 2014 Jul; 69(7):943-53. PubMed ID: 24898675
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical manifestations of hyper IgE syndromes.
    Freeman AF; Holland SM
    Dis Markers; 2010; 29(3-4):123-30. PubMed ID: 21178271
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An Indian Family with Autosomal Dominant Hyper-IgE Syndrome Due to IL6ST Defect.
    Basu S; Goel S; Rawat A; Vignesh P; Saikia B
    J Clin Immunol; 2024 Apr; 44(4):90. PubMed ID: 38578568
    [No Abstract]   [Full Text] [Related]  

  • 30. Successful haploidentical donor hematopoietic stem cell transplant and restoration of STAT3 function in an adolescent with autosomal dominant hyper-IgE syndrome.
    Patel NC; Gallagher JL; Torgerson TR; Gilman AL
    J Clin Immunol; 2015 Jul; 35(5):479-85. PubMed ID: 25962528
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hyper-IgE syndrome update.
    Sowerwine KJ; Holland SM; Freeman AF
    Ann N Y Acad Sci; 2012 Feb; 1250():25-32. PubMed ID: 22268731
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathogenesis of hyper IgE syndrome.
    Heimall J; Freeman A; Holland SM
    Clin Rev Allergy Immunol; 2010 Feb; 38(1):32-8. PubMed ID: 19452285
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Key findings to expedite the diagnosis of hyper-IgE syndromes in infants and young children.
    Hagl B; Heinz V; Schlesinger A; Spielberger BD; Sawalle-Belohradsky J; Senn-Rauh M; Magg T; Boos AC; Hönig M; Schwarz K; Dückers G; von Bernuth H; Pache C; Karitnig-Weiss C; Belohradsky BH; Frank J; Niehues T; Wahn V; Albert MH; Wollenberg A; Jansson AF; Renner ED
    Pediatr Allergy Immunol; 2016 Mar; 27(2):177-84. PubMed ID: 26592211
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intermediate phenotypes in patients with autosomal dominant hyper-IgE syndrome caused by somatic mosaicism.
    Hsu AP; Sowerwine KJ; Lawrence MG; Davis J; Henderson CJ; Zarember KA; Garofalo M; Gallin JI; Kuhns DB; Heller T; Milner JD; Puck JM; Freeman AF; Holland SM
    J Allergy Clin Immunol; 2013 Jun; 131(6):1586-93. PubMed ID: 23623265
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Generation of human induced pluripotent stem cell lines (NIHTVBi011-A, NIHTVBi012-A, NIHTVBi013-A) from autosomal dominant Hyper IgE syndrome (AD-HIES) patients carrying STAT3 mutation.
    Jin H; Yu Z; Navarengom K; Liu Y; Dmitrieva N; Hsu AP; Schwartzbeck R; Cudrici C; Ferrante EA; Yang D; Holland SM; Freeman AF; Boehm M; Chen G
    Stem Cell Res; 2019 Dec; 41():101586. PubMed ID: 31707214
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Potential and Limits of Hematopoietic Stem Cell Transplantation for the Treatment of Autosomal Dominant Hyper-IgE Syndrome.
    Yanagimachi M; Ohya T; Yokosuka T; Kajiwara R; Tanaka F; Goto H; Takashima T; Morio T; Yokota S
    J Clin Immunol; 2016 Jul; 36(5):511-6. PubMed ID: 27091139
    [TBL] [Abstract][Full Text] [Related]  

  • 37. STAT3-Mediated Transcriptional Regulation of Osteopontin in STAT3 Loss-of-Function Related Hyper IgE Syndrome.
    Goel S; Sahu S; Minz RW; Singh S; Suri D; Oh YM; Rawat A; Sehgal S; Saikia B
    Front Immunol; 2018; 9():1080. PubMed ID: 29868029
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TH17 Cells in STAT3 Related Hyper-IgE Syndrome.
    Sharma S; Saikia B; Goel S; Rawat A; Minz RW; Suri D; Chhabra S; Singh S
    Indian J Pediatr; 2016 Oct; 83(10):1104-8. PubMed ID: 27226025
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phenotyping and long-term follow up of patients with hyper IgE syndrome.
    Alyasin S; Esmaeilzadeh H; Ebrahimi N; Nabavizadeh SH; Kashef S; Esmaeilzadeh E; Babaei M; Amin R
    Allergol Immunopathol (Madr); 2019; 47(2):152-158. PubMed ID: 30279075
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hyper-IgE and Carcinoma in CADINS Disease.
    Pietzsch L; Körholz J; Boschann F; Sergon M; Dorjbal B; Yee D; Gilly V; Kämmerer E; Paul D; Kastl C; Laass MW; Berner R; Jacobsen EM; Roesler J; Aust D; Lee-Kirsch MA; Snow AL; Schuetz C
    Front Immunol; 2022; 13():878989. PubMed ID: 35651609
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.